TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Net Sales | ₹45 Cr | ₹32 Cr | ₹22 Cr |
What is the latest Revenue of TRIDENT LIFELINE ?
Year | Revenue |
---|---|
Mar2024 | ₹45 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹22 Cr |
How is Revenue of TRIDENT LIFELINE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹45 Cr | 40.82 | |
Mar2023 | ₹32 Cr | 45.59 | |
Mar2022 | ₹22 Cr | - |
Compare Revenue of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹313.2 Cr | 1.8% | -2.5% | 69.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 1.8% |
-2.5% |
69.4% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses